J&J COVID-19 vaccine gets approval for emergency use in India
image for illustrative purpose
Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines, said Health Minister Mansukh Mandaviya
As India expands its vaccine basket, Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines," said Health Minister Mansukh Mandaviya on August 7.
Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India.
The US-based pharmaceutical company had applied for Emergency Use Authorisation for its jab on August 6 and was granted approval the same day by the Drugs Controller General of India (DCGI), reported news agency PTI.
On August 6, the company said it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India. "On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India," a Johnson & Johnson India spokesperson said in a statement. This is an important milestone that paves the way for bringing the company's single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E Limited, the statement added.
Earlier on August 2, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.
The five vaccines granted Emergency Use Authorisation in India are Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson.
